Literature DB >> 1847522

gamma-Aminobutyric acid type A receptor point mutation increases the affinity of compounds for the benzodiazepine site.

D B Pritchett1, P H Seeburg.   

Abstract

Recombinantly expressed gamma-aminobutyric acid type A (GABAA) receptors consisting of alpha 1, beta 2, and gamma 2 subunits contain a binding site for benzodiazepines that differs in its properties from that of alpha 3 beta 2 gamma 2 receptors. Amino acid substitutions between the GABAA receptor alpha subunits were analyzed for their effect on the binding of compounds to the benzodiazepine site. By converting ever smaller regions of the alpha 3 subunit sequence to that of the alpha 1 subunit, we show that a single substitution (glycine for glutamic acid) increases the affinity for several compounds approximately 10-fold without changing the affinity for nonselective compounds. Hence, the identified amino acids may interact directly with the ligand and define part of the benzodiazepine binding sites in these receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847522      PMCID: PMC51030          DOI: 10.1073/pnas.88.4.1421

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Evidence for involvement of GABA in the action of benzodiazepines: studies on rat cerebellum.

Authors:  E Costa; A Guidotti; C C Mao
Journal:  Adv Biochem Psychopharmacol       Date:  1975

2.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

3.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

4.  Transmembrane topology and subcellular distribution of the benzodiazepine receptor.

Authors:  C Czajkowski; D H Farb
Journal:  J Neurosci       Date:  1986-10       Impact factor: 6.167

5.  Transient expression shows ligand gating and allosteric potentiation of GABAA receptor subunits.

Authors:  D B Pritchett; H Sontheimer; C M Gorman; H Kettenmann; P H Seeburg; P R Schofield
Journal:  Science       Date:  1988-12-02       Impact factor: 47.728

6.  Structural and functional basis for GABAA receptor heterogeneity.

Authors:  E S Levitan; P R Schofield; D R Burt; L M Rhee; W Wisden; M Köhler; N Fujita; H F Rodriguez; A Stephenson; M G Darlison
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

7.  A synthetic non-benzodiazepine ligand for benzodiazepine receptors: a probe for investigating neuronal substrates of anxiety.

Authors:  A S Lippa; J Coupet; E N Greenblatt; C A Klepner; B Beer
Journal:  Pharmacol Biochem Behav       Date:  1979-07       Impact factor: 3.533

8.  Acetylcholine receptor binding site contains a disulfide cross-link between adjacent half-cystinyl residues.

Authors:  P N Kao; A Karlin
Journal:  J Biol Chem       Date:  1986-06-25       Impact factor: 5.157

9.  Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA.

Authors:  M J Zoller; M Smith
Journal:  Nucleic Acids Res       Date:  1982-10-25       Impact factor: 16.971

10.  Structural and functional characterization of the gamma 1 subunit of GABAA/benzodiazepine receptors.

Authors:  S Ymer; A Draguhn; W Wisden; P Werner; K Keinänen; P R Schofield; R Sprengel; D B Pritchett; P H Seeburg
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

View more
  21 in total

Review 1.  Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels.

Authors:  A Devillers-Thiéry; J L Galzi; J L Eiselé; S Bertrand; D Bertrand; J P Changeux
Journal:  J Membr Biol       Date:  1993-11       Impact factor: 1.843

Review 2.  Brain GABAA receptors studied with subunit-specific antibodies.

Authors:  A L De Blas
Journal:  Mol Neurobiol       Date:  1996-02       Impact factor: 5.590

3.  Stoichiometry of a recombinant GABAA receptor.

Authors:  Y Chang; R Wang; S Barot; D S Weiss
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

4.  The gamma subunits of the native GABAA/benzodiazepine receptors.

Authors:  Z U Khan; A Gutiérrez; C P Miralles; A L De Blas
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

5.  Differences in expression of GABAA receptor subunits, but not benzodiazepine binding, in the chick brainstem auditory system.

Authors:  R L Hyson; K A Sadler
Journal:  J Mol Neurosci       Date:  1997-06       Impact factor: 3.444

Review 6.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

7.  The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones.

Authors:  T G Hales; J J Lambert
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

8.  The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit.

Authors:  P B Wingrove; K A Wafford; C Bain; P J Whiting
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

Review 9.  The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes.

Authors:  W Hevers; H Lüddens
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

Review 10.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.